SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - BIT:1SAN - FR0000120578 - Common Stock
86.13 EUR
+2.09 (+2.49%)
Overall 1SAN gets a fundamental rating of 6 out of 10. We evaluated 1SAN against 54 industry peers in the Pharmaceuticals industry. While 1SAN has a great profitability rating, there are some minor concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. Finally 1SAN also has an excellent dividend rating. These ratings could make 1SAN a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 11.05%, 1SAN is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
1SAN has a better Return On Equity (19.73%) than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.84%, 1SAN is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 14.71%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 20.35%. This is in the better half of the industry: 1SAN outperforms 79.63% of its industry peers.
1SAN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 23.59%, 1SAN is in line with its industry, outperforming 59.26% of the companies in the same industry.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin of 71.70%. This is comparable to the rest of the industry: 1SAN outperforms 55.56% of its industry peers.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1SAN has about the same amount of shares outstanding.
Compared to 5 years ago, 1SAN has about the same amount of shares outstanding.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
1SAN has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as 1SAN would need 2.21 years to pay back of all of its debts.
1SAN has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. 1SAN outperforms 83.33% of its industry peers.
1SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
1SAN has a Debt to Equity ratio of 0.21. This is in the better half of the industry: 1SAN outperforms 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.63%
2.3 Liquidity
1SAN has a Current Ratio of 1.27. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
1SAN has a Current ratio (1.27) which is in line with its industry peers.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
1SAN's Quick ratio of 0.94 is in line compared to the rest of the industry. 1SAN outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -2.20% in the last year.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 6.45% in the past year.
1SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
1SAN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.84% yearly.
Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.41, which indicates a very decent valuation of 1SAN.
1SAN's Price/Earnings ratio is a bit cheaper when compared to the industry. 1SAN is cheaper than 79.63% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.31. 1SAN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.93, the valuation of 1SAN can be described as reasonable.
1SAN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1SAN is cheaper than 79.63% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, 1SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 9.93 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA ratio is in line with the industry average.
1SAN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.84 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.77
PEG (5Y)2.24
EPS Next 2Y6.3%
EPS Next 3Y6.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.62%, 1SAN is a good candidate for dividend investing.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.04. 1SAN pays more dividend than 87.04% of the companies in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.62% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
BIT:1SAN (10/16/2025, 7:00:00 PM)
86.13
+2.09 (+2.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap209.90B
Analysts81.38
Price Target109.22 (26.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.62% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.17%
PT rev (3m)-5.79%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-5.89%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-2.05%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 9.93 | ||
| P/S | 3.09 | ||
| P/FCF | 20.84 | ||
| P/OCF | 18.44 | ||
| P/B | 3 | ||
| P/tB | 22.58 | ||
| EV/EBITDA | 10.8 |
EPS(TTM)7.55
EY8.77%
EPS(NY)8.68
Fwd EY10.07%
FCF(TTM)4.13
FCFY4.8%
OCF(TTM)4.67
OCFY5.42%
SpS27.86
BVpS28.73
TBVpS3.81
PEG (NY)2.77
PEG (5Y)2.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.93%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%